- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Novavax Inc+ Add to Watchlist
NVAX:US4.0100 USD 0.0300 0.75%
As of 20:10:00 ET on 12/04/2013.
Company Profile for Novavax Inc (NVAX)
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Key Executives for Novavax Inc (NVAX)
|Stanley C ErckPresident/CEO||Barclay A Phillips "Buck"Senior VP/CFO|
|Gregory M Glenn "Greg"Senior VP/Chief Medical Offcr||Timothy J HahnSenior VP:Manufacturing|
|Russell P Wilson "Rip"Senior VP:Business Development|